Hudson Bay Capital Management
OCEA

Hudson Bay Capital Management’s Ocean Biomedical, Inc. Common Stock OCEA Stock Holding History

Hudson Bay Capital Management’s Portfolio OCEA Stock Details OCEA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-528,000
Closed -$5.49M – 1034
2022
Q4 		$5.49M Hold
528,000
– – 0.06% 320
2022
Q3 		$5.38M Sell
528,000
-72,000
-12% -$734K 0.05% 381
2022
Q2 		$6.09M Hold
600,000
– – 0.05% 345
2022
Q1 		$6.05M Hold
600,000
– – 0.08% 289
2021
Q4 		$5.99M Buy
+600,000
New +$5.99M 0.06% 282

Other funds holding OCEA

PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
MC
Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return
CCFM
Cohen & Co Financial Management New York $18.3M AUM 73.48% 1-Year Est. Return
QL
Quarry LP New York $558M AUM 23.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
CSS
Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AI
Arena Investors Purchase, New York $12.5M AUM 0.27% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Hudson Bay Capital Management's OCEA Position: Q1 2023 in Review

Hudson Bay Capital Management sold out of Ocean Biomedical, Inc. Common Stock (OCEA) in Q1 2023, closing a stake of 528,000 shares — an estimated $5.49M sold.

Hudson Bay Capital Management first reported a position in OCEA in Q4 2021 and held it in 5 quarters. The position peaked at $6.09M in Q2 2022. 17 funds tracked by Wall St. Rank hold OCEA as of Q1 2023.

  • Hudson Bay Capital Management reported no remaining Ocean Biomedical, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Hudson Bay Capital Management sold 528,000 Ocean Biomedical, Inc. Common Stock shares in Q1 2023, an estimated $5.49M.
  • Hudson Bay Capital Management first reported a position in Ocean Biomedical, Inc. Common Stock in Q4 2021 and held it in 5 quarters.
  • Hudson Bay Capital Management's Ocean Biomedical, Inc. Common Stock position peaked at $6.09M in Q2 2022.
  • 17 funds tracked by Wall St. Rank held Ocean Biomedical, Inc. Common Stock as of Q1 2023.

Based on Hudson Bay Capital Management's 13F filing for Q1 2023, filed 15 May 2023.